Yifeng Pharmacy Chain Co., Ltd. (SHA: 603939)
China flag China · Delayed Price · Currency is CNY
23.55
-0.41 (-1.71%)
Nov 21, 2024, 3:00 PM CST

Yifeng Pharmacy Chain Statistics

Total Valuation

Yifeng Pharmacy Chain has a market cap or net worth of CNY 28.55 billion. The enterprise value is 26.69 billion.

Market Cap 28.55B
Enterprise Value 26.69B

Important Dates

The last earnings date was Thursday, October 31, 2024.

Earnings Date Oct 31, 2024
Ex-Dividend Date Oct 15, 2024

Share Statistics

Yifeng Pharmacy Chain has 1.21 billion shares outstanding. The number of shares has increased by 1.00% in one year.

Current Share Class n/a
Shares Outstanding 1.21B
Shares Change (YoY) +1.00%
Shares Change (QoQ) +0.58%
Owned by Insiders (%) 11.85%
Owned by Institutions (%) 19.42%
Float 555.39M

Valuation Ratios

The trailing PE ratio is 18.75 and the forward PE ratio is 17.74. Yifeng Pharmacy Chain's PEG ratio is 1.14.

PE Ratio 18.75
Forward PE 17.74
PS Ratio 1.19
PB Ratio 2.78
P/TBV Ratio n/a
P/FCF Ratio 6.66
P/OCF Ratio n/a
PEG Ratio 1.14
Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 7.04, with an EV/FCF ratio of 6.23.

EV / Earnings 17.52
EV / Sales 1.12
EV / EBITDA 7.04
EV / EBIT 12.39
EV / FCF 6.23

Financial Position

The company has a current ratio of 1.19, with a Debt / Equity ratio of 0.51.

Current Ratio 1.19
Quick Ratio 0.83
Debt / Equity 0.51
Debt / EBITDA 1.46
Debt / FCF 1.29
Interest Coverage 10.89

Financial Efficiency

Return on equity (ROE) is 15.79% and return on invested capital (ROIC) is 8.96%.

Return on Equity (ROE) 15.79%
Return on Assets (ROA) 5.48%
Return on Capital (ROIC) 8.96%
Revenue Per Employee 603,225
Profits Per Employee 38,417
Employee Count 39,652
Asset Turnover 0.97
Inventory Turnover 3.99

Taxes

Income Tax n/a
Effective Tax Rate n/a

Stock Price Statistics

The stock price has decreased by -24.09% in the last 52 weeks. The beta is 0.27, so Yifeng Pharmacy Chain's price volatility has been lower than the market average.

Beta (5Y) 0.27
52-Week Price Change -24.09%
50-Day Moving Average 22.86
200-Day Moving Average 28.22
Relative Strength Index (RSI) 44.99
Average Volume (20 Days) 14,928,872

Short Selling Information

Short Interest n/a
Short Previous Month n/a
Short % of Shares Out n/a
Short % of Float n/a
Short Ratio (days to cover) n/a

Income Statement

In the last 12 months, Yifeng Pharmacy Chain had revenue of CNY 23.92 billion and earned 1.52 billion in profits. Earnings per share was 1.26.

Revenue 23.92B
Gross Profit 9.23B
Operating Income 2.15B
Pretax Income 2.15B
Net Income 1.52B
EBITDA 2.36B
EBIT 2.15B
Earnings Per Share (EPS) 1.26
Full Income Statement

Balance Sheet

The company has 8.06 billion in cash and 5.55 billion in debt, giving a net cash position of 2.51 billion or 2.07 per share.

Cash & Cash Equivalents 8.06B
Total Debt 5.55B
Net Cash 2.51B
Net Cash Per Share 2.07
Equity (Book Value) 10.90B
Book Value Per Share 8.46
Working Capital 2.39B
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 5.08 billion and capital expenditures -796.24 million, giving a free cash flow of 4.29 billion.

Operating Cash Flow 5.08B
Capital Expenditures -796.24M
Free Cash Flow 4.29B
FCF Per Share 3.54
Full Cash Flow Statement

Margins

Gross margin is 38.59%, with operating and profit margins of 9.00% and 6.37%.

Gross Margin 38.59%
Operating Margin 9.00%
Pretax Margin 8.99%
Profit Margin 6.37%
EBITDA Margin 9.87%
EBIT Margin 9.00%
FCF Margin 17.92%

Dividends & Yields

This stock pays an annual dividend of 0.50, which amounts to a dividend yield of 2.09%.

Dividend Per Share 0.50
Dividend Yield 2.09%
Dividend Growth (YoY) n/a
Years of Dividend Growth 1
Payout Ratio 35.04%
Buyback Yield -1.00%
Shareholder Yield 1.09%
Earnings Yield 5.33%
FCF Yield 15.02%
Dividend Details

Stock Splits

The last stock split was on June 7, 2024. It was a forward split with a ratio of 1.2.

Last Split Date Jun 7, 2024
Split Type Forward
Split Ratio 1.2

Scores

Yifeng Pharmacy Chain has an Altman Z-Score of 2.83. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score 2.83
Piotroski F-Score n/a